Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine /atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)HOBBS, F. D. Richard; GENSINI, Gianfranco; METCALFE, Michael et al.International journal of cardiology. 2006, Vol 110, Num 2, pp 242-250, issn 0167-5273, 9 p.Article

Differential involvement of cyclooxygenase isoforms in neutrophil migration in vivo and in vitroBATISTA MENEZES, Gustavo; REZENDE, Rafael Machado; MARQUES PEREIRA-SILVA, Pedro Elias et al.European journal of pharmacology. 2008, Vol 598, Num 1-3, pp 118-122, issn 0014-2999, 5 p.Article